COVID-19 in Pediatrics: Demographic, Clinical, Laboratory, and Radiological Characteristics of Infected Patients With SARS-CoV-2.
COVID-19
Gorgan
Iran
SARS-CoV-2
children
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
11
2021
accepted:
21
12
2021
entrez:
31
1
2022
pubmed:
1
2
2022
medline:
1
2
2022
Statut:
epublish
Résumé
The COVID-19 disease usually leads to mild infectious disease in children, but some develop serious complications. Here, we describe the characteristics of children with COVID-19 in northern Iran, the Golestan province. Ninety-one confirmed cases were enrolled in the study, aged 0-18 years. Demographic, clinical, comorbidity, laboratory, and radiological data were compared based on the disease severity (admitted to intensive care unit (ICU) or not) and disease outcome (recovered or deceased). Sixteen (17.5%) cases were hospitalized in ICU, and 8/91 (8.8%) deceased. Fever and cough were the most common clinical symptoms. Among all symptoms notified there were no significant differences between severe and milder cases, or between those who deceased and recovered. Failure to thrive (FTT), malignant disease and neurological disease were significantly more prevalent in severe cases as was frequently reported comorbidities. Laterality, ground-glass opacity, and lung consolidation were the most common findings in chest computed tomography. The data confirms that the COVID-19 disease has various presentations in children, and clinical, laboratory, and radiological findings may help predict the development of severe forms of COVID-19 among children.
Identifiants
pubmed: 35096716
doi: 10.3389/fped.2021.808187
pmc: PMC8793734
doi:
Types de publication
Journal Article
Langues
eng
Pagination
808187Informations de copyright
Copyright © 2022 Najafinejad, Cheraghali, Aghcheli, Rajabi, Barati, Naziri, Gharib, Tabarraei, Nakstad and Tahamtan.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Pediatr. 2020 Jul;179(7):1029-1046
pubmed: 32424745
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992388
Neurosci Lett. 2021 Jan 19;743:135567
pubmed: 33352286
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):529-534
pubmed: 33668003
J Infect Public Health. 2020 Dec;13(12):1791-1796
pubmed: 33127335
Eur J Radiol. 2020 Oct;131:109236
pubmed: 32932176
AJR Am J Roentgenol. 2020 Dec;215(6):1303-1311
pubmed: 32442030
Acta Myol. 2021 Mar 31;40(1):1-7
pubmed: 33870093
Am J Emerg Med. 2020 Sep;38(9):1722-1726
pubmed: 32738466
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Respir Med. 2021 Apr-May;180:106356
pubmed: 33713961
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Dermatol Ther. 2020 Jul;33(4):e13594
pubmed: 32412681
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Crit Care. 2021 Mar 25;25(1):121
pubmed: 33766109
Front Med (Lausanne). 2020 Dec 23;7:614152
pubmed: 33425957
North Clin Istanb. 2020 May 04;7(3):284-291
pubmed: 32478302
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Int J Pediatr. 2021 Apr 28;2021:5558287
pubmed: 34007286
BMC Med. 2020 Sep 3;18(1):270
pubmed: 32878619
Quant Imaging Med Surg. 2020 May;10(5):1058-1079
pubmed: 32489929
Front Pediatr. 2021 Apr 20;9:565778
pubmed: 33959568
Hepatol Res. 2020 Aug;50(8):924-935
pubmed: 32386449
Int J Infect Dis. 2020 May;94:128-132
pubmed: 32251805
Int J Infect Dis. 2021 Feb;103:246-256
pubmed: 33227520
Epidemiol Infect. 2020 Aug 28;148:e196
pubmed: 32854812
Future Virol. 2021 Sep;:
pubmed: 34650617
J Blood Med. 2021 Sep 04;12:819-826
pubmed: 34512062
Pediatr Ann. 2020 Dec 1;49(12):e516-e522
pubmed: 33290569
Lancet Infect Dis. 2020 Jun;20(6):689-696
pubmed: 32220650
Int J Antimicrob Agents. 2020 Aug;56(2):106054
pubmed: 32534188
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
BMC Infect Dis. 2021 Feb 1;21(1):133
pubmed: 33522901
Expert Rev Respir Med. 2020 Nov;14(11):1149-1163
pubmed: 32734777
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028
pubmed: 32286245
Expert Rev Respir Med. 2020 Apr;14(4):415-423
pubmed: 31995408
Br J Radiol. 2020 Sep 01;93(1113):20200647
pubmed: 32730110
Front Pediatr. 2021 Mar 04;9:619738
pubmed: 33748041
Expert Rev Respir Med. 2020 Sep;14(9):881-888
pubmed: 32536226
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Viruses. 2020 Mar 27;12(4):
pubmed: 32230900
J Trop Pediatr. 2021 Jul 2;67(3):
pubmed: 32692815
Nat Med. 2022 Jan;28(1):185-192
pubmed: 34764489
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Clin Virol. 2020 Jun;127:104378
pubmed: 32353762
Expert Rev Respir Med. 2020 Oct;14(10):965-967
pubmed: 32576053
PLoS One. 2021 Jun 21;16(6):e0252939
pubmed: 34153056
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
J Pediatric Infect Dis Soc. 2019 Mar 28;8(1):21-28
pubmed: 29447395